Central functional response to the novel peptide cannabinoid, hemopressin
Authors:
- Garron T. DoddGDGarron T. Dodd
- Amy A. WorthAWAmy A. Worth
- Duncan J. HodkinsonDHDuncan J. Hodkinson
- Raj K. SrivastavaRSRaj K. Srivastava
- Beat LutzBLBeat Lutz
- Steve R. WilliamsSWSteve R. Williams
- Simon M. LuckmanSLSimon M. Luckman
- 1 August 2013
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 71, 27-36
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Endocannabinoids: An appetite for fatProceedings of the National Academy of Sciences, 2011
- Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes2011
- The Peptide Hemopressin Acts through CB1Cannabinoid Receptors to Reduce Food Intake in Rats and MiceJournal of Neuroscience, 2010
- The endocannabinoid system in obesity and type 2 diabetesDiabetologia, 2008
- Endogenous Cannabinoids: Structure and MetabolismJournal of Neuroendocrinology, 2008
- Glutamate and the Neural Basis of the Subjective Effects of KetamineArchives of General Psychiatry, 2008
- Optimization of Neuropeptide Extraction from the Mouse HypothalamusJournal of Proteome Research, 2007
- Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trialsThe Lancet, 2007
- The endocannabinoid system and its therapeutic exploitationNature Reviews Drug Discovery, 2004
- Synaptic input and output of parvalbumin-immunoreactive neurons in the neostriatum of the ratNeuroscience, 1994